ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-α1 transgene efficacy

被引:5
作者
Noisakran, S
Härle, P
Carr, DJJ
机构
[1] Univ Oklahoma, Dept Ophthalmol, Dean McGee Eye Inst, OUHSC, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Dept Ophthalmol, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA
关键词
HSV-1; ICAM-1; IFN-alpha; plasmid DNA; cytokine;
D O I
10.1006/viro.2001.0858
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to determine the role of ICAM-1 in ocular herpes simplex virus type 1 (HSV-1) infection. Wild-type and ICAM-1 knockout mice were assessed for resistance to ocular HSV-1 infection in the presence of naked DNA plasmid vector or plasmid DNA encoding interferon-alpha1 topically applied to the cornea of the mice. Wild-type mice showed greater resistance to HSV-1 infection compared to ICAM-1 knockout mice as measured by cumulative survival. The absence of ICAM-1 did not affect the efficacy of the interferon-al transgene against ocular HSV-1. Both ICAM-1 and wild-type mice treated with the transgene showed a reduction in viral load and antigen expression in the trigeminal ganglion compared to the plasmid vector-treated counterparts. In contrast, the presence of the transgene reduced the number of infiltrating cells into the cornea in comparison to plasmid vector DNA controls in the wild-type mice but not in the ICAM-1 knockout mice. Collectively, these results suggest that the IFN-alpha1 transgene can restore resistance against HSV-1 infection in ICAM-1-deficient mice. (C) 2001 Academic Press.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 50 条
  • [21] Effects of morphine on replication of herpes simplex virus type 1 and 2
    Monavari, Seyed Hamid Reza
    Shahrabadi, Mahmoud Shamsi
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (20): : 2945 - 2948
  • [22] Inhibitory effects of baicalein against herpes simplex virus type 1
    Luo, Zhuo
    Kuang, Xiu-Ping
    Zhou, Qing-Qing
    Yan, Chang-Yu
    Li, Wen
    Gong, Hai-Biao
    Kurihara, Hiroshi
    Li, Wei-Xi
    Li, Yi-Fang
    He, Rong-Rong
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (12) : 2323 - 2338
  • [23] Primary target cells of herpes simplex virus type 1 in the hippocampus
    Ando, Yoshinori
    Kitayama, Hiroko
    Kawaguchi, Yasushi
    Koyanagi, Yoshio
    MICROBES AND INFECTION, 2008, 10 (14-15) : 1514 - 1523
  • [24] Exposure to herpes simplex virus, type 1 and reduced cognitive function
    Thomas, Pramod
    Bhatia, Triptish
    Gauba, Deepak
    Wood, Joel
    Long, Colleen
    Prasad, Konasale
    Dickerson, Faith B.
    Gur, Raquel E.
    Gur, Ruben C.
    Yolken, Robert H.
    Nimgaonkar, Vishwajit L.
    Deshpande, Smita N.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (11) : 1680 - 1685
  • [25] In vitro nuclear egress of herpes simplex virus type 1 capsids
    Remillard-Labrosse, Gaudeline
    Lippe, Roger
    METHODS, 2011, 55 (02) : 153 - 159
  • [26] Seroepidemiology of Herpes Simplex Virus Type 1 and 2 in Northern Iran
    Rezaei-Chaparpordi, S.
    Assmar, M.
    Amirmozafari, N.
    Modiri, L.
    Massiha, A.
    Shokri-Fashtali, S.
    Gholizadeh, Z.
    Akbari, S.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2012, 41 (08) : 75 - 79
  • [27] Seaweeds with anti-herpes simplex virus type 1 activity
    Barros, Caroline de Souza
    Teixeira, Valeria Laneuville
    Paixao, Izabel Christina N. P.
    JOURNAL OF APPLIED PHYCOLOGY, 2015, 27 (04) : 1623 - 1637
  • [28] Seaweeds with anti-herpes simplex virus type 1 activity
    Caroline de Souza Barros
    Valéria Laneuville Teixeira
    Izabel Christina N. P. Paixão
    Journal of Applied Phycology, 2015, 27 : 1623 - 1637
  • [29] Antiviral Activity of Oridonin Against Herpes Simplex Virus Type 1
    Jiang, Kai
    Feng, Jing
    Qi, Xia
    Ran, Lili
    Xie, Lixin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 4311 - 4323
  • [30] Herpes Simplex Virus 1, Macrophages, and the Cornea
    Carr, Daniel J. J.
    JOURNAL OF VIROLOGY, 2017, 91 (21)